VOFATAMAB
UNII JMH6YR91PG

Substance Identification & Data

This profile provides standardized clinical and technical data for Vofatamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JMH6YR91PG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1312305-12-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

JMH6YR91PG

CAS Registry Number

1312305-12-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VOFATAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C116863

National Cancer Institute reference terminology for clinical and research data.

INN ID

10919

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-149

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vofatamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VOFATAMAB

Common Names & Synonyms

ANTI-FGFR3 MONOCLONAL ANTIBODY MFGR1877S

MFGR 1877S [WHO-DD]

RECOMBINANT HUMAN IGG1 KAPPA ANTI-FIBROBLAST GROWTH FACTOR RECEPTOR 3 MONOCLONAL ANTIBODY B-701

VOFATAMAB [INN]

VOFATAMAB [USAN]

VOFATAMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR TYPE 3) (HUMAN MONOCLONAL MFGR1877S HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MFGR1877S .KAPPA.-CHAIN, DIMER

SYS

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS FGFR3 (FIBROBLAST GROWTH FACTOR RECEPTOR 3, CD333)), MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN (1-457) (VH (HOMO SAPIENS IGHV3-66*01 (85.7%)-(IGHD)-IGHJ4*01 (100%)) (8.8.20) (1-127)-HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (224) (128-225), HINGE (226-240), CH2 (241-350), CH3 E12 (366), M14 (368) (351-455), CHS (456-457)) (128-457)), (230-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-5*01 (86.7%)-IGKJ1*01 (100%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01, KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (236-236'':239-239'')-BISDISULFIDE

SYS

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR-3, ANTIGEN CD333))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-457) (HOMO SAPIENS VH (IGHV3-66*01 (86%) (IGHD)-IGHJ4*01) (8.8.20) (1-127)-HOMO SAPIENS IGHG1*03 (CH1(R97>K(224))) (128-457)) (230-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV1-5*01 (87%) IGKJ1*01)(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (236-236'':239-239'')-BISDISULFIDE

SYS